Stockreport

Dong-A ST Secures European Approval for Stelara Biosimilar IMULDOSA [Yahoo! Finance]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF SEOUL, South Korea, December 19, 2024 BUSINESS WIRE Dong-A ST (CEO: Jeong Jae-hoon, KRX: 170900) proudly announces that its Stelara biosimilar, IMULDOSA (Project Name: [Read more]